/주식/DVAX
DVAX

DVAX

Dynavax Technologies Corporation Common Stock

$10.400+0.000 (0.000%)

실시간 가격

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$10.400

고가

$10.400

저가

$10.400

거래량

1.30M

기업 기본 정보

거래 통계

관련 뉴스

PR Newswire

Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting

Dynavax Technologies Corporation (Nasdaq: DVAX) ("Dynavax" or the "Company"), a commercial-stage biopharmaceutical company developing and...

더 보기
Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting
BusinessWire

Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom

Deep Track's Nominees Are Prepared to Collectively Enter the Boardroom with Open-Minded Perspectives, Constructive Approach and Sole Focus on Creating Value for All Shareholders Believes that Without Meaningful Board

더 보기
Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom
PR Newswire

Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting

Dynavax Technologies Corporation (Nasdaq: DVAX) ("Dynavax" or the "Company"), a commercial-stage biopharmaceutical company developing and...

더 보기
Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting
PR Newswire

Dynavax Comments on Glass Lewis Recommendation

Dynavax Technologies Corporation (Nasdaq: DVAX) ("Dynavax" or the "Company"), a commercial-stage biopharmaceutical company developing and...

더 보기
Dynavax Comments on Glass Lewis Recommendation
BusinessWire

Glass Lewis Recommends Shareholders Support Deep Track's Case for Board Change at Dynavax Technologies

Glass Lewis Recommends Shareholders Vote FOR Deep Track Nominees Brett Erkman and Donald Santel and AGAINST Chairman Scott Myers and Director Brent MacGregor Notes that "Deep Track has Highlighted Valid and Critical

더 보기
Glass Lewis Recommends Shareholders Support Deep Track's Case for Board Change at Dynavax Technologies
PR Newswire

Dynavax to Present at William Blair's 45th Annual Growth Stock Conference

Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines,...

BusinessWire

Deep Track Capital Comments on ISS Recommendation

Strongly Disagrees with Recommendation and Believes ISS Ignored Key Issues in Its Incomplete Analysis ISS Has Chosen Not to Hold the Board Accountable for Its Underperformance in Recent Years, Heplisav's Waning Market